Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TETRACYCLINE CAP 250MG 250 MG

TETRACYCLINE HYDROCHLORIDE : 250 MG · DIN 00448729 · DUCHESNAY INC

Health Canada status: CANCELLED POST MARKET

What is TETRACYCLINE CAP 250MG?

TETRACYCLINE CAP 250MG 250 MG contains TETRACYCLINE HYDROCHLORIDE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 00448729, held by DUCHESNAY INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-Jul-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00448729
Brand nameTETRACYCLINE CAP 250MG
Generic / active ingredientTETRACYCLINE HYDROCHLORIDE : 250 MG
ManufacturerDUCHESNAY INC
Strength250 MG
Dosage formCAPSULE
Route of administrationORAL
SchedulePrescription
ATC codeJ01AA07 TETRACYCLINE
AHFS class08:12.24
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date18-Jul-2003
Original market date1981-12-31 00:00:00

Is TETRACYCLINE in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by AA PHARMA INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for TETRACYCLINE CAP 250MG

What can be used instead?

Other Canadian products sharing ATC code J01AA07 TETRACYCLINE. 1 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
TETRACYCLINE250 MGCAPSULEAA PHARMA INCMARKETEDDIN 00580929
ACHROMYCIN V CAP 250MG250 MGCAPSULELEDERLE CYANAMID CANADA INC.CANCELLED POST MARKETDIN 00014605
APO TETRA TABS 250MG250 MGTABLETAPOTEX INCCANCELLED POST MARKETDIN 00603252
JAA TETRA TAB 250MG250 MGTABLETJAAPHARM CANADA INC.CANCELLED POST MARKETDIN 00889393
MEDICYCLINE CAP 250MG250 MGCAPSULEMEDIC LABORATORY LTÉECANCELLED POST MARKETDIN 00134406
NOVO-TETRA 250MG250 MGCAPSULENOVOPHARM LIMITEDCANCELLED POST MARKETDIN 00021059
NOVO-TETRA 250MG250 MGTABLETNOVOPHARM LIMITEDCANCELLED POST MARKETDIN 00021806
NOVO-TETRA SUS 125MG/5ML125 MG / 5 MLLIQUIDNOVOPHARM LIMITEDCANCELLED POST MARKETDIN 00151416
NU-TETRA CAPSULES 250MG250 MGCAPSULENU-PHARM INCCANCELLED POST MARKETDIN 00717606
TETRACYCLINE CAP 250MG250 MGCAPSULEPRO DOC LIMITEECANCELLED POST MARKETDIN 00156744

Who else supplies TETRACYCLINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. TETRACYCLINE appears in 24 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TETRACYCLINE CAP 250MG

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 00448729. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.